The Zhitong Finance App learned that the latest 2026 revenue guidance issued by the US comprehensive healthcare service company CVS.US (CVS.US) is lower than the average expectations of Wall Street analysts, mainly because the company is going through a turbulent retail environment and the US government is facing stricter scrutiny by the US government as a whole. However, the company raised earnings expectations for the full year and emphasized that 2026 profits are expected to continue to expand under multiple pressures such as regulation. This is a hopeful sign as the company deals with a volatile retail environment and more stringent scrutiny.

The Zhitong Finance App learned that the latest 2026 revenue guidance issued by the US comprehensive healthcare service company CVS.US (CVS.US) is lower than the average expectations of Wall Street analysts, mainly because the company is going through a turbulent retail environment and the US government is facing stricter scrutiny by the US government as a whole. However, the company raised earnings expectations for the full year and emphasized that 2026 profits are expected to continue to expand under multiple pressures such as regulation. This is a hopeful sign as the company deals with a volatile retail environment and more stringent scrutiny.